Viatris Inc.

7.51
-0.03 (-0.40%)
At close: Apr 14, 2025, 1:06 PM
-0.40%
Bid 7.5
Market Cap 8.96B
Revenue (ttm) 14.73B
Net Income (ttm) -634.2M
EPS (ttm) -0.53
PE Ratio (ttm) -14.17
Forward PE 4.24
Analyst Hold
Ask 7.52
Volume 4,794,784
Avg. Volume (20D) 14,906,677.4
Open 7.67
Previous Close 7.54
Day's Range 7.42 - 7.68
52-Week Range 6.85 - 13.55
Beta 0.91

About VTRS

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, end...

Sector Healthcare
IPO Date Mar 17, 1980
Employees 32,000
Stock Exchange NASDAQ
Ticker Symbol VTRS
Full Company Profile

Analyst Forecast

According to 4 analyst ratings, the average rating for VTRS stock is "Hold." The 12-month stock price forecast is $10, which is an increase of 33.16% from the latest price.

Stock Forecasts

Next Earnings Release

Viatris Inc. is scheduled to release its earnings on May 8, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-0.13%
Viatris shares are trading lower after the company... Unlock content with Pro Subscription
1 month ago
-15.21%
Viatris shares are trading lower after the company reported Q4 EPS and sales below estimates, and issued FY25 revenue and EPS guidance below estimates.